Hansa Biopharma to initiate Phase 3 study of imlifidase to treat anti-Glomerular Basement ... - WFMZ

Retrieved on: 2021-11-15 14:02:44

Tags for this article:

Click the tags to see associated articles and topics

Hansa Biopharma to initiate Phase 3 study of imlifidase to treat anti-Glomerular Basement ... - WFMZ. View article details on hiswai:

Excerpt

MALMO, Sweden, Nov. 15, 2021 /PRNewswire/ -- Hansa Biopharma AB, "Hansa" (Nasdaq Stockholm: HNSA), today announces its decision to initiate a ...

Article found on: www.wfmz.com